Barclays PLC Olink Holding Ab (Publ) Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$14.29 - $25.95 $1,429 - $2,595	-100 Reduced 50.0%	100 $3,000
Q3 2023 Nov 07, 2023	BUY	$14.45 - $20.34 $1,445 - $2,034	100 Added 100.0%	200 $2,000
Q4 2022 Feb 13, 2023	SELL	$12.64 - $25.52 $222,046 - $448,309	-17,567 Reduced 99.43%	100 $3,000
Q3 2022 Nov 03, 2022	SELL	$12.14 - $18.42 $7.31 Million - $11.1 Million	-602,173 Reduced 97.15%	17,667 $214,000
Q2 2022 Aug 12, 2022	BUY	$8.95 - $19.24 $266,727 - $573,390	29,802 Added 5.05%	619,840 $9.42 Million
Q1 2022 May 16, 2022	BUY	$11.33 - $19.3 $6.69 Million - $11.4 Million	590,038 New	590,038 $10.4 Million

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.